|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
The main aim of this study is to critically investigate in current up-to-date the technology of rDNA and its biomedical applications as therapeutic proteins. rDNA is the new technology and is a field of molecular biology where scientist reshape the DNA to form synthetic molecular that help to cure many diseases related to human being. A therapeutic proteins are proteins engineered in laboratory for pharmaceutical purpose, making of insulin is one of the most important benefits ever could be achieved by this technology. Therapeutic proteins are also used in different treatment such as Anemia, Hemophilia, Cancer, Hepatitis B and C and many more. A specific host cell like Bacteria is required to generate rDNA technology based protein.These proteins have a huge impact not only in disease related to human but also benefits agricultural and industry, on the other hand, there is a huge safety concerns affiliated with rDNA such as Virus's developing treatment resistance. However, the future of rDNAproducts as therapeutic proteins is looking bright in term of new development in science and technology.